Epitope-specific immunotherapy of rheumatoid arthritis: Clinical responsiveness occurs with immune deviation and relies on the expression of a cluster of molecules associated with T cell tolerance in a double-blind, placebo-controlled, pilot phase II trial

✍ Scribed by Eva C. Koffeman; Mark Genovese; Diane Amox; Elissa Keogh; Ernesto Santana; Eric L. Matteson; Arthur Kavanaugh; Jerry A. Molitor; Michael H. Schiff; James O. Posever; Joan M. Bathon; Alan J. Kivitz; Rodrigo Samodal; Francis Belardi; Carolyn Dennehey; Theo van den Broek; Femke van Wijk; Xiao Zhang; Peter Zieseniss; Tho Le; Berent A. Prakken; Gary C. Cutter; Salvatore Albani

• Publisher: John Wiley and Sons
• Year: 2009
• Tongue: English
• Weight: 192 KB
• Volume: 60
• Category: Article
• ISSN: 0004-3591
• DOI: 10.1002/art.24916